Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Blood Cancer Discovery
Wang, Victoria E VE; Blaser, Bradley W BW; Patel, Ravi K RK; Behbehani, Gregory K GK; Rao, Arjun A AA; Durbin-Johnson, Blythe B; Jiang, Tommy T; Logan, Aaron C AC; Settles, Matthew M; Mannis, Gabriel N GN; Olin, Rebecca R; Damon, Lloyd E LE; Martin, Thomas G TG; Sayre, Peter H PH; Gaensler, Karin M KM; McMahon, Emma E; Flanders, Michael M; Weinberg, Vivian V; Ye, Chun J CJ; Carbone, David P DP; Munster, Pamela N PN; Fragiadakis, Gabriela K GK; McCormick, Frank F; Andreadis, Charalambos C